Skip to content

The Buckle BKE Available-for-Sale Securities (Non-Current)

Available-for-Sale Securities (Non-Current) at other companies

Hubbell logo
HubbellHUBB
$99.8M+14.8%
Teradyne, Inc. logo
Teradyne, Inc.TER
$148.37M+30.4%
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$469.54M-0.9%
HubSpot logo
HubSpotHUBS
$87.52M-50.4%
Royalty Pharma logo
Royalty PharmaRPRX
$406.8M+85.8%
Hims & Hers Health logo
Hims & Hers HealthHIMS
$0

Other financials

Income statement

See full
Revenue$288.7M+6.1%
Gross profit$133.5M+5.1%
Operating income$59.5M+36.5%
Net income$46.9M+33.2%
EPS (diluted)$0.92+31.4%

Balance sheet

See full
Cash & equivalents$266.2M-1.0%
Total debt$410.9M+11.1%
Total equity$458.9M+3.1%
Total assets$1.0B+7.3%

Cash flow

See full
Operating cash flow$49.3M+59.2%
CapEx$14.7M+28.6%
Free cash flow$34.7M+77.1%

Valuation

See full
Market cap$2.3B+59.6%

Profitability

See full
Gross margin48.9%+0.1pp
Operating margin21.1%+1.3pp
Net margin16.8%+0.9pp
FCF margin16.8%+0.5pp

Returns & leverage

See full
Return on equity49%+4.4pp
Debt / equity0.9×+0.1×
Current ratio-0.1×

Where this comes from

Reported directly by The Buckle in its filing.

Tagged under the XBRL concept us-gaap:MarketableSecuritiesNoncurrent.

The official record: The Buckle’s 10-Q, filed June 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Buckle's available-for-sale securities (non-current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is The Buckle's available-for-sale securities (non-current)?
The Buckle (BKE) reported available-for-sale securities (non-current) of $33.81M in Q1 2026.
How has The Buckle's available-for-sale securities (non-current) changed year-over-year?
The Buckle's available-for-sale securities (non-current) increased by 19.6% year-over-year, from $28.28M to $33.81M.
What is the long-term trend for The Buckle's available-for-sale securities (non-current)?
Over 5 years (2020 to 2025), The Buckle's available-for-sale securities (non-current) has grown at a 12.1% compound annual growth rate (CAGR), from $18.32M to $32.39M.